BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34892054)

  • 1. Analysis of tumour microstructure estimation from conventional diffusion MRI and application to skull-base chordoma
    Morelli L; Buizza G; Palombo M; Riva G; Fontana G; Imparato S; Iannalfi A; Orlandi E; Paganelli C; Baroni G
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():3761-3764. PubMed ID: 34892054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microstructural parameters from DW-MRI for tumour characterization and local recurrence prediction in particle therapy of skull-base chordoma.
    Morelli L; Palombo M; Buizza G; Riva G; Pella A; Fontana G; Imparato S; Iannalfi A; Orlandi E; Paganelli C; Baroni G
    Med Phys; 2023 May; 50(5):2900-2913. PubMed ID: 36602230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating skull base chordomas and invasive pituitary adenomas with conventional MRI.
    Gao A; Bai J; Cheng J; Cheng X; Li S; Zhang Z; Zhang Y
    Acta Radiol; 2018 Nov; 59(11):1358-1364. PubMed ID: 29448805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI-based tumour control probability in skull-base chordomas treated with carbon-ion therapy.
    Buizza G; Molinelli S; D'Ippolito E; Fontana G; Pella A; Valvo F; Preda L; Orecchia R; Baroni G; Paganelli C
    Radiother Oncol; 2019 Aug; 137():32-37. PubMed ID: 31051372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the characterization of meningioma microstructure in proton therapy from conventional apparent diffusion coefficient measurements using Monte Carlo simulations of diffusion MRI.
    Buizza G; Paganelli C; Ballati F; Sacco S; Preda L; Iannalfi A; Alexander DC; Baroni G; Palombo M
    Med Phys; 2021 Mar; 48(3):1250-1261. PubMed ID: 33369744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of DW MR imaging in the differentiation of chordomas and chondrosarcomas of the skull base: A 3.0-T MRI study of 105 cases.
    Welzel T; Meyerhof E; Uhl M; Huang K; von Deimling A; Herfarth K; Debus J
    Eur J Radiol; 2018 Aug; 105():119-124. PubMed ID: 30017267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisitation of imaging features of skull base chondrosarcoma in comparison to chordoma.
    Hasegawa H; Shin M; Niwa R; Koizumi S; Yoshimoto S; Shono N; Shinya Y; Takami H; Tanaka S; Umekawa M; Amemiya S; Kin T; Saito N
    J Neurooncol; 2022 Sep; 159(3):581-590. PubMed ID: 35882753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a role for conventional MRI and MR diffusion-weighted imaging for distinction of skull base chordoma and chondrosarcoma?
    Müller U; Kubik-Huch RA; Ares C; Hug EB; Löw R; Valavanis A; Ahlhelm FJ
    Acta Radiol; 2016 Feb; 57(2):225-32. PubMed ID: 25722460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging signal characteristics associated with prognosis of skull base chordoma after gamma knife radiosurgery.
    Hu YS; Lee CC; Wu CA; Lin CJ; Yang HC; Guo WY; Liu KD; Chung WY; Shiau CY; Wu HM
    J Neurooncol; 2023 Jan; 161(1):45-56. PubMed ID: 36565364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of optimal b-value sets for obtaining apparent diffusion coefficient free from perfusion in non-small cell lung cancer.
    Karki K; Hugo GD; Ford JC; Olsen KM; Saraiya S; Groves R; Weiss E
    Phys Med Biol; 2015 Oct; 60(20):7877-91. PubMed ID: 26406921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerate gas diffusion-weighted MRI for lung morphometry with deep learning.
    Duan C; Deng H; Xiao S; Xie J; Li H; Zhao X; Han D; Sun X; Lou X; Ye C; Zhou X
    Eur Radiol; 2022 Jan; 32(1):702-713. PubMed ID: 34255160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microstructural characterization of normal and malignant human prostate tissue with vascular, extracellular, and restricted diffusion for cytometry in tumours magnetic resonance imaging.
    Panagiotaki E; Chan RW; Dikaios N; Ahmed HU; O'Callaghan J; Freeman A; Atkinson D; Punwani S; Hawkes DJ; Alexander DC
    Invest Radiol; 2015 Apr; 50(4):218-27. PubMed ID: 25426656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DW-MRI of the urogenital tract: applications in oncology.
    Petralia G; Thoeny HC
    Cancer Imaging; 2010 Oct; 10 Spec no A(1A):S112-23. PubMed ID: 20880781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronal diffusion-weighted magnetic resonance imaging of the kidney: agreement with axial diffusion-weighted magnetic imaging in terms of apparent diffusion coefficient values.
    Wang HY; Wang J; Tang YH; Ye HY; Ma L
    Chin Med J (Engl); 2015 Feb; 128(4):499-503. PubMed ID: 25673453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of apparent diffusion coefficient (ADC) values in differentiating benign and malignant skull lesions with histopathological (HPE) correlation.
    Mahendrakar AK; Kumaran SP; Reddy BN; Viswamitra S
    J Clin Neurosci; 2022 Apr; 98():21-28. PubMed ID: 35131721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Diffusion-Weighted Magnetic Resonance Imaging and Apparent Diffusion Coefficient in Gastric Cancer Staging.
    Soydan L; Demir AA; Torun M; Cikrikcioglu MA
    Curr Med Imaging; 2020; 16(10):1278-1289. PubMed ID: 32108000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced Diffusion-Weighted MRI for Cancer Microstructure Assessment in Body Imaging, and Its Relationship With Histology.
    Fokkinga E; Hernandez-Tamames JA; Ianus A; Nilsson M; Tax CMW; Perez-Lopez R; Grussu F
    J Magn Reson Imaging; 2023 Nov; ():. PubMed ID: 38032021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo assessment of optimal b-value range for perfusion-insensitive apparent diffusion coefficient imaging.
    Freiman M; Voss SD; Mulkern RV; Perez-Rossello JM; Callahan MJ; Warfield SK
    Med Phys; 2012 Aug; 39(8):4832-9. PubMed ID: 22894409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted MR imaging including bi-exponential fitting for the detection of recurrent or residual tumour after (chemo)radiotherapy for laryngeal and hypopharyngeal cancers.
    Tshering Vogel DW; Zbaeren P; Geretschlaeger A; Vermathen P; De Keyzer F; Thoeny HC
    Eur Radiol; 2013 Feb; 23(2):562-9. PubMed ID: 22865270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted MRI: distinction of skull base chordoma from chondrosarcoma.
    Yeom KW; Lober RM; Mobley BC; Harsh G; Vogel H; Allagio R; Pearson M; Edwards MS; Fischbein NJ
    AJNR Am J Neuroradiol; 2013 May; 34(5):1056-61, S1. PubMed ID: 23124635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.